We are live on
!
Find out more
BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.05B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+8.86%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
-$289K
(-0.02%)
Cap. Flow
-$70.9M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
61.59%
Holding
114
New
32
Increased
13
Reduced
19
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$51.1M |
| 2 |
Hilton Worldwide
HLT
|
+$48.1M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$42.4M |
| 4 |
Northrop Grumman
NOC
|
+$35.2M |
| 5 |
CSX Corp
CSX
|
+$31.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$54.4M |
| 2 |
O'Reilly Automotive
ORLY
|
+$28.8M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$26.3M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$26.2M |
| 5 |
RTN
Raytheon Company
RTN
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.86% |
| 2 | Industrials | 17.05% |
| 3 | Consumer Discretionary | 12.99% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
51
DELISTED
Medicines Co
MDCO
| $1.86M | 0.14% |
+56,504
| New | +$1.77M |
|
52
Exelixis
EXEL
$13.1B
| $1.66M | 0.12% |
+74,802
| New | +$2.07M |
|
53
PUT
Amgen
AMGN
$226B
| $917K | 0.07% |
+865
| New | +$159K |
|
|
ARD
54
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $912K | 0.07% |
48,834
-4,830
| -9% | -$93.2K |
|
55
CALL
AstraZeneca
AZN
$251B
| $480K | 0.03% |
+1,800
| New | +$125K |
|
|
CTXS
56
CALL
DELISTED
Citrix Systems Inc
CTXS
| $413K | 0.03% |
+1,333
| New | +$123K |
|
57
Curis
CRIS
$7.13M
| $377K | 0.03% |
288
-29
| -9% | -$38K |
|
58
PUT
Vertex Pharmaceuticals
VRTX
$133B
| $372K | 0.03% |
+600
| New | +$98K |
|
59
CALL
Ball Corp
BALL
$16.6B
| $331K | 0.02% |
2,500
-1,800
| -42% | -$70.4K |
|
60
PUT
Bristol-Myers Squibb
BMY
$132B
| $241K | 0.02% |
1,500
-5,500
| -79% | -$354K |
|
|
61
CALL
Bristol-Myers Squibb
BMY
$132B
| $168K | 0.01% |
+1,750
| New | +$113K |
|
|
AVXS
62
CALL
DELISTED
AveXis, Inc. Common Stock
AVXS
| $158K | 0.01% |
+210
| New | +$25K |
|
63
PUT
GSK
GSK
$104B
| $140K | 0.01% |
+5,600
| New | +$261K |
|
|
64
CALL
Exelixis
EXEL
$13.1B
| $135K | 0.01% |
+2,850
| New | +$78.8K |
|
65
CALL
Merck
MRK
$323B
| $127K | 0.01% |
+2,934
| New | +$158K |
|
66
Spyre Therapeutics
SYRE
$9.29B
| $95K | 0.01% |
+384
| New | +$69.4K |
|
|
ALXN
67
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $82K | 0.01% |
+450
| New | +$53.8K |
|
68
PUT
Aon
AON
$75.7B
| – | – |
-1,000
| Closed | -$208K |
|
69
PUT
ATI
ATI
$31.1B
| – | – |
-2,500
| Closed | -$938K |
|
70
CALL
Biogen
BIIB
$30.6B
| – | – |
-1,750
| Closed | -$210K |
|
71
Casey's General Stores
CASY
$31.6B
| – | – |
-194,759
| Closed | -$21.8M |
|
|
CLLS
72
Cellectis
CLLS
$278M
| – | – |
-97,710
| Closed | -$2.85M |
|
73
CALL
Comcast
CMCSA
$89.4B
| – | – |
-3,850
| Closed | -$552K |
|
74
Capital One
COF
$134B
| – | – |
-119,210
| Closed | -$11.9M |
|
75
Dover
DOV
$28.3B
| – | – |
-255,266
| Closed | -$20.8M |
|
Similar funds
WF
DCM
AB
MFBTD
IAS
SA
TL
ACM
Bain Capital Public Equity Management's Q1 2018 Portfolio in Review
As of Q1 2018, Bain Capital Public Equity Management held 114 positions worth $1.37B, down 0.02% from $1.38B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Bain Capital Public Equity Management withdrew a net $70.9M in Q1 2018, closing 47 positions and reducing 19 holdings. Its most notable exit was Ultimate Software Group Inc, an estimated $26.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 48% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Bain Capital Public Equity Management opened a new position in Coca-Cola Europacific Partners worth $44.8M.
- Bain Capital Public Equity Management's largest Q1 2018 buy was Coca-Cola Europacific Partners: 1,074,372 shares worth $44.8M.
- Bain Capital Public Equity Management added most to Honeywell in Q1 2018, an estimated $51.1M increase.
- Bain Capital Public Equity Management's biggest Q1 2018 reduction was NXP Semiconductors, cutting an estimated $54.4M.
- Bain Capital Public Equity Management fully exited Ultimate Software Group Inc in Q1 2018, selling an estimated $26.3M.
- Bain Capital Public Equity Management's ten largest holdings make up 62% of its $1.37B portfolio in Q1 2018.
- Bain Capital Public Equity Management opened 32 new positions and closed 47 in Q1 2018.
- Bain Capital Public Equity Management's portfolio value fell 0.02% quarter-over-quarter to $1.37B.
Based on Bain Capital Public Equity Management's 13F filing for Q1 2018, filed 15 May 2018.